Personalized circulating tumor DNA analysis for sensitive disease monitoring and detection of relapse in neuroblastoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Personalized circulating tumor DNA analysis for sensitive disease monitoring and detection of relapse in neuroblastoma ; volume:12 ; number:1 ; day:26 ; month:11 ; year:2024 ; pages:1-6 ; date:12.2024
Biomarker Research ; 12, Heft 1 (26.11.2024), 1-6, 12.2024
- Urheber
-
Rahmqvist, Ida
Engström, Enya
Mellström, Elisabeth
Ibrahim, Raghda R.
Pujol-Calderón, Fani
Dahlstrand Rudin, Agnes
Ordqvist Redfors, Anna
Rostamzadeh, Niki
Di Rienzo, Rita
Franssila, Wilma
Khashan, Robert
Xylander, Moe
Karlsson, Christin
Ek, Torben
Andersson, Daniel
Österlund, Tobias
Gaarder, Jennie
Fagman, Henrik
Fransson, Susanne
Martinsson, Tommy
Ståhlberg, Anders
Dalin, Martin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40364-024-00688-5
- URN
-
urn:nbn:de:101:1-2502112145354.717118589051
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rahmqvist, Ida
- Engström, Enya
- Mellström, Elisabeth
- Ibrahim, Raghda R.
- Pujol-Calderón, Fani
- Dahlstrand Rudin, Agnes
- Ordqvist Redfors, Anna
- Rostamzadeh, Niki
- Di Rienzo, Rita
- Franssila, Wilma
- Khashan, Robert
- Xylander, Moe
- Karlsson, Christin
- Ek, Torben
- Andersson, Daniel
- Österlund, Tobias
- Gaarder, Jennie
- Fagman, Henrik
- Fransson, Susanne
- Martinsson, Tommy
- Ståhlberg, Anders
- Dalin, Martin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Circulating tumor DNA in early‐stage breast cancer: personalized biomarkers for occult metastatic disease and risk of relapse?
Serum brain-derived neurotrophic factor (BDNF) as predictors of childhood neuroblastoma relapse
Circulating tumor DNA for personalized lung cancer monitoring
Personalized relapse prediction in patients with major depressive disorder using digital biomarkers
Circulating tumor DNA detection improves relapse prediction in epithelial ovarian cancer
123I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis
Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma
The Relapse
Highly-sensitive capture of circulating tumor cells using micro-ellipse filters
Imaging in neuroblastoma
Personalized signaling models for personalized treatments
Personalized signaling models for personalized treatments
Circulating tumor DNA in early‐stage breast cancer: personalized biomarkers for occult metastatic disease and risk of relapse?
Serum brain-derived neurotrophic factor (BDNF) as predictors of childhood neuroblastoma relapse
Circulating tumor DNA for personalized lung cancer monitoring
Personalized relapse prediction in patients with major depressive disorder using digital biomarkers
Circulating tumor DNA detection improves relapse prediction in epithelial ovarian cancer
123I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis
Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma
The Relapse
Highly-sensitive capture of circulating tumor cells using micro-ellipse filters
Imaging in neuroblastoma
Personalized signaling models for personalized treatments
Personalized signaling models for personalized treatments
Circulating tumor DNA in early‐stage breast cancer: personalized biomarkers for occult metastatic disease and risk of relapse?
Serum brain-derived neurotrophic factor (BDNF) as predictors of childhood neuroblastoma relapse
Circulating tumor DNA for personalized lung cancer monitoring
Personalized relapse prediction in patients with major depressive disorder using digital biomarkers
Circulating tumor DNA detection improves relapse prediction in epithelial ovarian cancer
123I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis
Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma
The Relapse
Highly-sensitive capture of circulating tumor cells using micro-ellipse filters
Imaging in neuroblastoma
Personalized signaling models for personalized treatments